Non-irritant concentrations and amounts of active ingredient in drug patch tests

A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

(2012) A. Barbaud et al.   BRITISH JOURNAL OF DERMATOLOGY

Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients

(2012) S. GIORGINI et al.   Dermatologic Therapy

A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions

(2012) Y.-T. Lin et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Patch testing in fixed drug eruptions-a 20-year review

(2011) Pedro Andrade et al.   CONTACT DERMATITIS

Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)

(2010) Felicidade Santiago et al.   CONTACT DERMATITIS

Propylthiouracil-induced DRESS syndrome confirmed by a positive patch test

(2009) Y.-M. Ye et al.   ALLERGY

Skin Testing in Delayed Reactions to Drugs

(2009) Annick Barbaud   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions

(2008) J. Waton et al.   BRITISH JOURNAL OF DERMATOLOGY

Patch tests with desloratadine at 10% induce false-positive results: test at 1%

(2008) A Barbaud et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY